FIGURE 1.

Trial design.
AGI, alpha glucosidase inhibitor; degludec, insulin degludec; IDegLira, insulin degludec/liraglutide; OAD, oral antidiabetic drug; SU, sulphonylurea; TZD, thiazolidinedione; V, visit.

Trial design.
AGI, alpha glucosidase inhibitor; degludec, insulin degludec; IDegLira, insulin degludec/liraglutide; OAD, oral antidiabetic drug; SU, sulphonylurea; TZD, thiazolidinedione; V, visit.